Huma Granted Class II Clearance By FDA For Its Disease-Agnostic Platform
Huma’s platform is now the only remote patient monitoring platform approved in both the US and Europe that is able to aid clinicians in their work.

Huma’s platform is now the only remote patient monitoring platform approved in both the US and Europe that is able to aid clinicians in their work.